Latest Transformation News

Amcor plc reported a 10% increase in net sales for fiscal 2025 following its merger with Berry Global Group, Inc., yet net income fell 30% amid significant integration expenses and higher debt costs. The company aims to unlock $530 million in synergies by 2028 while navigating global economic and operational risks.

oOh!media Limited reported a robust 17% increase in revenue for the first half of 2025, driven by strong Australian market segments, but posted a statutory loss due to a significant impairment charge in New Zealand. The company also announced a restructuring and a new CEO appointment.

BlueScope Steel reported a resilient FY2025 with $738 million underlying EBIT despite soft market conditions, advancing key growth and decarbonisation initiatives. The company extends its buy-back program and maintains a strong balance sheet as it targets significant earnings uplift by 2030.

The a2 Milk Company delivered record FY25 results with $1.9 billion in sales and announced a transformative acquisition of a New Zealand manufacturing facility, alongside divesting its stake in Mataura Valley Milk and planning a $300 million special dividend.

The a2 Milk Company reported a robust 21% rise in net profit for FY25, driven by strong growth in China and the USA, alongside a landmark full-year dividend declaration and major supply chain restructuring.

The a2 Milk Company reported record FY25 results with $1.9 billion in sales and declared its first-ever dividends, while advancing a major supply chain overhaul through a key New Zealand manufacturing acquisition and divestment.

Almonty Industries reported a challenging Q2 2025 with a significant non-cash loss but strengthened its position through a Nasdaq listing, a major U.S. defense offtake agreement, and progress at its flagship Sangdong mine.

Neurizon Therapeutics faces a delay in FDA review for its lead ALS therapy NUZ-001, with a new decision expected by early October amid agency-wide staffing challenges.

EMVision Medical Devices has been awarded a $3 million non-dilutive government grant to conduct a pioneering clinical study using its telehealth-enabled emu™ brain scanner in regional South Australia, aiming to transform stroke diagnosis and treatment.

McPherson’s Limited has finalized a key pharmacy wholesaler agreement with API Services Australia, marking the completion of its new distribution model and transitioning significant revenue previously handled direct-to-store.

Miramar Resources has extended its Share Purchase Plan closing date to 27 August 2025, giving shareholders more time to invest at a 20% discount as the company awaits critical exploration results.

Amcor has completed its transformative acquisition of Berry Global, reporting a 43% jump in quarterly net sales and projecting strong earnings growth for fiscal 2026. The company’s strategic portfolio review and synergy realisation efforts underpin an optimistic outlook.